Apollo Hospitals Enterprise Limited

BSE:508869 Stock Report

Market Cap: ₹896.0b

Apollo Hospitals Enterprise Valuation

Is 508869 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 508869 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 508869 (₹6230.3) is trading above our estimate of fair value (₹3010.5)

Significantly Below Fair Value: 508869 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 508869?

Other financial metrics that can be useful for relative valuation.

508869 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.1x
Enterprise Value/EBITDA45.3x
PEG Ratio3.2x

Price to Earnings Ratio vs Peers

How does 508869's PE Ratio compare to its peers?

The above table shows the PE ratio for 508869 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average60.8x
543220 Max Healthcare Institute
73.9x20.5%₹781.1b
MEDANTA Global Health
79.6x24.4%₹359.8b
FORTIS Fortis Healthcare
56.4x27.6%₹311.9b
NH Narayana Hrudayalaya
33.4x8.8%₹257.9b
508869 Apollo Hospitals Enterprise
113.5x35.9%₹896.0b

Price-To-Earnings vs Peers: 508869 is expensive based on its Price-To-Earnings Ratio (113.5x) compared to the peer average (60.8x).


Price to Earnings Ratio vs Industry

How does 508869's PE Ratio compare vs other companies in the IN Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a26.8%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a26.8%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 508869 is expensive based on its Price-To-Earnings Ratio (113.5x) compared to the Indian Healthcare industry average (37.6x).


Price to Earnings Ratio vs Fair Ratio

What is 508869's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

508869 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio113.5x
Fair PE Ratio72.5x

Price-To-Earnings vs Fair Ratio: 508869 is expensive based on its Price-To-Earnings Ratio (113.5x) compared to the estimated Fair Price-To-Earnings Ratio (72.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 508869 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹6,230.30
₹6,970.88
+11.9%
10.7%₹7,850.00₹4,200.00n/a26
Mar ’25₹6,082.75
₹6,970.88
+14.6%
10.7%₹7,850.00₹4,200.00n/a26
Feb ’25₹6,287.45
₹6,119.62
-2.7%
9.3%₹7,000.00₹4,200.00n/a26
Jan ’25₹5,748.00
₹5,881.73
+2.3%
7.3%₹6,291.00₹4,200.00n/a26
Dec ’24₹5,586.30
₹5,877.88
+5.2%
7.3%₹6,291.00₹4,200.00n/a26
Nov ’24₹4,794.90
₹5,564.79
+16.1%
8.1%₹6,260.00₹4,200.00n/a24
Oct ’24₹5,137.40
₹5,543.54
+7.9%
7.8%₹6,260.00₹4,200.00n/a24
Sep ’24₹4,837.65
₹5,518.80
+14.1%
7.6%₹6,260.00₹4,200.00n/a25
Aug ’24₹5,030.60
₹5,383.50
+7.0%
7.9%₹6,260.00₹4,200.00n/a22
Jul ’24₹5,095.60
₹5,376.71
+5.5%
5.0%₹5,950.00₹4,730.00n/a21
Jun ’24₹4,818.60
₹5,328.24
+10.6%
4.0%₹5,698.00₹4,730.00n/a21
May ’24₹4,519.95
₹5,223.43
+15.6%
4.6%₹5,600.00₹4,690.00n/a21
Apr ’24₹4,309.40
₹5,249.81
+21.8%
4.1%₹5,700.00₹4,730.00n/a21
Mar ’24₹4,415.80
₹5,251.35
+18.9%
4.1%₹5,700.00₹4,730.00₹6,082.7520
Feb ’24₹4,268.10
₹5,227.15
+22.5%
4.1%₹5,600.00₹4,730.00₹6,287.4520
Jan ’24₹4,478.65
₹5,225.35
+16.7%
4.1%₹5,600.00₹4,730.00₹5,748.0020
Dec ’23₹4,774.10
₹5,225.35
+9.5%
4.1%₹5,600.00₹4,730.00₹5,586.3020
Nov ’23₹4,509.20
₹5,018.65
+11.3%
3.8%₹5,420.00₹4,730.00₹4,794.9020
Oct ’23₹4,383.25
₹5,011.55
+14.3%
3.9%₹5,420.00₹4,730.00₹5,137.4020
Sep ’23₹4,279.40
₹5,060.32
+18.2%
5.5%₹5,935.00₹4,730.00₹4,837.6522
Aug ’23₹4,288.25
₹4,882.64
+13.9%
8.1%₹5,935.00₹4,336.00₹5,030.6022
Jul ’23₹3,735.15
₹4,865.14
+30.3%
9.0%₹5,935.00₹4,180.00₹5,095.6022
Jun ’23₹3,839.05
₹4,857.77
+26.5%
9.1%₹5,935.00₹4,180.00₹4,818.6022
May ’23₹4,457.75
₹5,515.55
+23.7%
4.7%₹6,250.00₹5,222.00₹4,519.9522
Apr ’23₹4,503.05
₹5,556.91
+23.4%
5.7%₹6,350.00₹4,970.00₹4,309.4022
Mar ’23₹4,801.55
₹5,526.79
+15.1%
5.9%₹6,350.00₹4,970.00₹4,415.8019

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.